Constraining a peptide in its bioactive conformation by macrocyclization represents a powerful strategy to design modulators of challenging biomolecular targets. This holds particularly true for the development of inhibitors of protein-protein interactions which often involve interfaces lacking defined binding pockets. Such flat surfaces are demanding targets for traditional small molecules rendering macrocyclic peptides promising scaffolds for novel therapeutics. However, the contribution of peptide dynamics to binding kinetics is barely understood which impedes the design process. Herein, we report unexpected trends in the binding kinetics of two closely related macrocyclic peptides that bind their receptor protein with high affinity. Iso...
Macrocycles have been emerging as a very important drug class in the past few decades largely due to...
Macrocyclic peptides can interfere with challenging biomolecular targets including protein-protein i...
Macrocyclic peptides can interfere with challenging biomolecular targets including protein-protein i...
Constraining a peptide in its bioactive conformation by macrocyclization represents a powerful strat...
Constraining a peptide in its bioactive conformation by macrocyclization represents a powerful strat...
Constraining a peptide in its bioactive conformation by macrocyclization represents a powerful strat...
Cyclic peptides that are potent regulators of biological processes are rapidly emerging as important...
Large and flexible ligands gain increasing interest in the development of bioactive agents. They cha...
\u3cp\u3eMacrocyclic peptides can interfere with challenging biomolecular targets including protein-...
De novo macrocyclic peptides, derived using selection technologies such as phage and mRNA display, p...
Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein i...
De novo macrocyclic peptides, derived using selection technologies such as phage and mRNA display, p...
Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein i...
De novo macrocyclic peptides, derived using selection technologies such as phage and mRNA display, p...
G proteins represent intracellular switches that transduce signals relayed from G protein-coupled re...
Macrocycles have been emerging as a very important drug class in the past few decades largely due to...
Macrocyclic peptides can interfere with challenging biomolecular targets including protein-protein i...
Macrocyclic peptides can interfere with challenging biomolecular targets including protein-protein i...
Constraining a peptide in its bioactive conformation by macrocyclization represents a powerful strat...
Constraining a peptide in its bioactive conformation by macrocyclization represents a powerful strat...
Constraining a peptide in its bioactive conformation by macrocyclization represents a powerful strat...
Cyclic peptides that are potent regulators of biological processes are rapidly emerging as important...
Large and flexible ligands gain increasing interest in the development of bioactive agents. They cha...
\u3cp\u3eMacrocyclic peptides can interfere with challenging biomolecular targets including protein-...
De novo macrocyclic peptides, derived using selection technologies such as phage and mRNA display, p...
Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein i...
De novo macrocyclic peptides, derived using selection technologies such as phage and mRNA display, p...
Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein i...
De novo macrocyclic peptides, derived using selection technologies such as phage and mRNA display, p...
G proteins represent intracellular switches that transduce signals relayed from G protein-coupled re...
Macrocycles have been emerging as a very important drug class in the past few decades largely due to...
Macrocyclic peptides can interfere with challenging biomolecular targets including protein-protein i...
Macrocyclic peptides can interfere with challenging biomolecular targets including protein-protein i...